Detection of lymph node metastasis in patients with nodal prostate cancer relapse using 18F/11C-choline positron emission tomography/computerized tomography

Journal of Urology

Volumn 192, Issue 1, 2014, Pages 103-111

  Jilg, Cordula A ^a   Schultze Seemann, Wolfgang ^a   Drendel, Vanessa ^a   Vach, Werner ^a   Wieser, Gesche ^a   Krauss, Tobias ^a   Jandausch, Anett ^a   Hölz, Stefanie ^a   Henne, Karl ^a   Reske, Sven N ^b   Grosu, Anca L ^d   Weber, Wolfgang A ^a,c   Rischke, H Christian ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d Memorial Sloan Kettering Cancer Center ^*

Author keywords

computerized tomography; emission computed; lymph node dissection; neoplasm metastasis; positron emission tomography; prostate

Indexed keywords

CHOLINE C 11; FLUOROETHYLCHOLINE F 18; IOMEPROL; IOPROMIDE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; CARBON; CHOLINE; FLUOROETHYLCHOLINE; METHYL CARBON-11 CHOLINE; PROSTATE SPECIFIC ANTIGEN; TRACER;

ADULT; AORTA; AORTA BIFURCATION; ARTICLE; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CAVA VEIN; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HISTOPATHOLOGY; HUMAN; ILIAC CREST; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OBTURATOR; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PET-CT SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SALVAGE THERAPY; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION; TUMOR VOLUME; WHOLE BODY PET; AGED; ANALOGS AND DERIVATIVES; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; LYMPHATIC METASTASIS; MULTIMODAL IMAGING; NEOPLASM RECURRENCE, LOCAL; POSITRON EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; BOLUS INJECTION; CANCER INFILTRATION; CANCER SCINTISCANNING; COMPUTED TOMOGRAPHY SCANNER; COMPUTER SYSTEM; CONTRAST ENHANCEMENT; GLEASON SCORE; HUMAN TISSUE; NODAL PROSTATE CANCER;

AGED; CARBON RADIOISOTOPES; CHOLINE; HUMANS; LYMPHATIC METASTASIS; MALE; MULTIMODAL IMAGING; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84902506150     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.12.054     Document Type: Article

References (30)

1. M. Han, A.W. Partin, and M. Zahurak Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer J Urol 169 2003 517
2. S.A. Boorjian, R.H. Thompson, and M.K. Tollefson et al. Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence Eur Urol 59 2011 893
3. M.N. Simmons, A.J. Stephenson, and E.A. Klein Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy Eur Urol 51 2007 1175
4. H.C. Rischke, S. Knippen, and S. Kirste et al. Treatment of recurrent prostate cancer following radical prostatectomy: the radiation-oncologists point of view Q J Nucl Med Mol Imaging 56 2012 409
5. C.S. Higano Side effects of androgen deprivation therapy: monitoring and minimizing toxicity Urology 61 2003 32
6. R.C. Benson Total androgen blockade: the United States experience Eur Urol 24 1993 72
7. P. Rigatti, N. Suardi, and A. Briganti Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography Eur Urol 60 2011 935
8. C.A. Jilg, H.C. Rischke, and W. Schultze-Seemann Salvage lymph node dissection with adjuvant radiotherapy for choline-PET-CT positive lymph nodes in patients with nodal recurrence of prostate cancer J Urol 188 2012 2190
9. A.M. Hovels, R.A. Heesakkers, and E.M. Adang The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis Clin Radiol 63 2008 387
10. L. Rinnab, F.M. Mottaghy, and N.M. Blumstein et al. Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer BJU Int 100 2007 786
11. S.N. Reske, N.M. Blumstein, and G. Glatting [11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy Eur J Nucl Med Mol Imaging 35 2008 9
12. B.J. Krause, M. Souvatzoglou, and M. Tuncel et al. The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer Eur J Nucl Med Mol Imaging 35 2008 18
13. P. Castellucci, C. Fuccio, and C. Nanni et al. Influence of trigger PSA and PSA kinetics on 11C-choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy J Nucl Med 50 2009 1394
14. 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? Eur J Nucl Med Mol Imaging 38 2011 55
15. G. Giovacchini, M. Picchio, and V. Scattoni et al. PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy Eur J Nucl Med Mol Imaging 37 2010 1106
16. G. Giovacchini, M. Picchio, and R.G. Parra et al. Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy Clin Nucl Med 37 2012 325
17. M. Cimitan, R. Bortolus, and S. Morassut et al. [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients Eur J Nucl Med Mol Imaging 33 2006 1387
18. E. Pelosi, V. Arena, and A. Skanjeti et al. Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer Radiol Med 113 2008 895
19. D.B. Husarik, R. Miralbell, and M. Dubs et al. Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer Eur J Nucl Med Mol Imaging 35 2008 253
20. F. Casamassima, L. Masi, and C. Menichelli et al. Efficacy of eradicative radiotherapy for limited nodal metastases detected with choline PET scan in prostate cancer patients Tumori 97 2011 49
21. M. Picchio, A. Briganti, and S. Fanti et al. The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer Eur Urol 59 2011 51
22. M. Haseebuddin, F. Dehdashti, and B.A. Siegel et al. 11C-acetate PET/CT before radical prostatectomy: nodal staging and treatment failure prediction J Nucl Med 54 2013 699
23. D. Tilki, O. Reich, and A. Graser et al. 18F-fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent Eur Urol 63 2013 792
24. V. Scattoni, M. Picchio, and N. Suardi Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy Eur Urol 52 2007 423
25. M.H. Umbehr, M. Muntener, and T. Hany et al. The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis Eur Urol 64 2013 106
26. C.J. McMahon, N.M. Rofsky, and I. Pedrosa Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging Radiology 254 2010 31
27. M. Beheshti, L. Imamovic, and G. Broinger et al. 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients Radiology 254 2010 925
28. R. Schiavina, V. Scattoni, and P. Castellucci et al. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms Eur Urol 54 2008 392
29. K. Contractor, A. Challapalli, and T. Barwick et al. Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression Clin Cancer Res 17 2011 7673
30. T. Hara, N. Kosaka, and H. Kishi Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging J Nucl Med 43 2002 187